Upgrade to SI Premium - Free Trial

Rogers (ROG)

127.94 -12.57 (8.95%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/27/26)
- M&A (12/31/22 *Est)

Latest Headlines

Rogers Corp (ROG) PT Lowered to $195 at B.Riley October 22, 2026 8:13 AM - StreetInsider Rogers Corporation Schedules Third Quarter 2026 Earnings Call for October 27 October 13, 2026 4:05 PM - BizWire Rogers Corp (ROG) PT Raised to $225 at B.Riley October 1, 2026 8:39 AM - StreetInsider Rogers Corporation Provides 2030 Financial Targets at 2026 Investor Day September 30, 2026 4:05 PM - BizWire Rogers Corporation to Host Investor Day on September 30, 2026 September 30, 2026 6:55 AM - BizWire Rogers Corporation Announces Investor Day on September 30, 2026 September 9, 2026 4:38 PM - BizWire Form 4 ROGERS CORP For: Sep 05 Filed by: Russell Laura September 9, 2026 2:25 PM - SEC Filing Roche wins FDA nod for HER2 companion diagnostics in GEA August 26, 2026 2:52 PM - StreetInsider Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA August 26, 2026 2:52 PM - PR NewsWire Azenta names board member as interim CEO after Marotta resigns August 24, 2026 8:01 AM - StreetInsider AZENTA ANNOUNCES LEADERSHIP TRANSITION August 24, 2026 8:00 AM - PR NewsWire Form 4 ROGERS CORP For: Aug 14 Filed by: Reeder Raymond Sean August 17, 2026 4:23 PM - SEC Filing Form SCHEDULE 13G/A ROGERS CORP Filed by: Capital Research Global Investors August 12, 2026 5:08 PM - SEC Filing Form SCHEDULE 13G/A ROGERS CORP Filed by: NORGES BANK August 12, 2026 6:37 AM - SEC Filing Form 10-Q ROGERS CORP For: Jun 30 July 29, 2026 6:02 AM - SEC Filing Rogers (ROG) Tops Q2 EPS by 13c; Offers Guidance July 28, 2026 4:15 PM - StreetInsider Form 8-K ROGERS CORP For: Jul 28 July 28, 2026 4:07 PM - SEC Filing Rogers Corporation Reports Second Quarter 2026 Results July 28, 2026 4:05 PM - BizWire Roche wins FDA clearance for vaginitis PCR diagnostic test July 24, 2026 8:31 AM - StreetInsider Roche receives FDA clearance for the cobas® BV/CV assay, enabling fast and highly accurate vaginitis diagnosis July 24, 2026 8:30 AM - PR NewsWire Full Article List